Exercise and Brain Health in Multiple Sclerosis: A Pilot Study

CompletedNot a drug-phase studyRelapsing MSNCT03638739

What it found

No results found

We found no results in the registry or in papers.

This trial finished 7 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Twice-weekly exercise

What it measured

Main measures

  • Change in Perceived Fatigue

    Outcome will be measured at Baseline, 12 weeks and 24 weeks.

    Fatigue
  • Change in Inflammatory Markers

    Outcome will be measured at Baseline, 12 weeks and 24 weeks.

    Immune response
  • Change in Depression

    Outcome will be measured at Baseline, 12 weeks and 24 weeks.

    Mood and sleep
  • Change in Cognition

    Outcome will be measured at Baseline, 12 weeks and 24 weeks.

    Thinking and memory

Other measures (3)

  • Change in Aerobic Capacity

    Outcomes will be measured at Baseline, 12 weeks and 24 weeks.

    Physical function
  • Change in Muscle Strength

    Outcomes will be measured at Baseline, 12 weeks and 24 weeks.

    Physical function
  • Change in Perceived Quality of Life (QOL)

    Outcomes will be measured at Baseline, 12 weeks and 24 weeks.

    Quality of life (reported by participants)

Who could take part

Relapsing MS · 18 to 65 · EDSS 2 to 5

Show the full criteria

Inclusion criteria

* Diagnosis of Relapsing-Remitting MS (RRMS) with mild-moderate disability (EDSS 2-5) * Aged 18-60 * Score of ≥ 10 on MFIS-5* * Medical clearance to participate in physical activity * The MFIS-5 is an abbreviated version of the 21-item MFIS, consisting of 5 of the 21 items of the MFIS that most strongly correlate with the total MFIS score. A score ≥ 10 on the MFIS-5 is considered to indicate "high-level" of fatigue

Exclusion criteria

* Current participation in regular physical activity (at least twice-weekly) * Other serious medical condition that might impair ability to participate in strength or aerobic exercise

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Physical activity is now recognized as a therapy for Multiple Sclerosis (MS) that not only improves physical fitness and functional mobility, but there is some evidence that it may also positively influence the more invisible symptoms of the disease that represent "brain health" - fatigue, depression and cognitive impairment. One important feature of physical activity is that it reduces inflammation throughout the body and the brain. The goal of this research is to determine whether people with MS feel less fatigue, depression and cognitive impairment after a program of exercise because there is a decrease in the state of inflammation in the brain.

Loading reviews and guidelines…

History

    1. Started

      Aug 2018

    2. Main results due

      Jun 2019

    3. Finished

      Sept 2019

    Assembled by software from public sources.